MicroRNA-based therapy of postmyocardial infarction heart failure

Hellenic J Cardiol. 2021 Mar-Apr;62(2):149-151. doi: 10.1016/j.hjc.2021.03.006. Epub 2021 Apr 20.

Authors

Simon Tual-Chalot¹, Konstantinos Stellos²

Affiliations

¹ Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
² Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK; Department of Cardiology, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK. Electronic address: konstantinos.stellos@ncl.ac.uk.

PMID: 33852921
DOI: 10.1016/j.hjc.2021.03.006

No abstract available

Publication types

Editorial
Comment

MeSH terms

Heart Failure* / therapy
Humans
MicroRNAs* / genetics
Myocardial Infarction* / complications
Myocardial Infarction* / therapy
Syndrome

Substances

MicroRNAs